About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

1 [1] (December 3, 2024)

handle is hein.crs/govermh0001 and id is 1 raw text is: 




Congressional Research &
Informing the legislitive debate s~nee 191


ice


                                                                                      Updated December  3, 2024
The Advisory Committee on Immunization Practices (ACIP)


The Advisory Committee on Immunization Practices
(ACIP) is a committee of nonfederal experts who make
recommendations to the Department of Health and Human
Services (HHS) regarding the use of vaccines and related
agents for the control of vaccine-preventable disease in the
U.S. civilian population. As a critical function, ACIP
recommendations inform the Centers for Disease Control
and Prevention's (CDC's) annual immunization schedules
of recommended  vaccines for both children and adolescents
(18 years of age and younger) and adults (19 years of age
and older). ACIP may also make recommendations
regarding nonroutine vaccines, including for travel or for
use in emergency situations such as the Coronavirus
Disease 2019 (COVID-19)  pandemic or mpox outbreaks.

ACP Estabishment and History
The Surgeon General established ACIP in March 1964
under Section 222 of the Public Health Service Act (PHSA;
42 U.S.C. §217a), a general authority that allows the HHS
Secretary to convene advisory committees. ACIP was
created to provide ongoing expert advice to the Secretary
on federal immunization policy in response to expanded
federal immunization programs and the licensure of several
new vaccines. In 1972, ACIP was designated a federal
advisory committee under the Federal Advisory Committee
Act (FACA,  P.L. 92-463; provisions of FACA have moved
to 5 U.S.C. Chapter 10).

Over ew
Today, ACIP provides recommendations to CDC, a leading
federal agency for immunization programs. The committee
remains authorized under general authority and is governed
by its official charter per FACA requirements. However,
under several federal laws, ACIP and its recommendations
play a role in defining the relevant statutory requirements
(as explained in the Statutory Roles section.)

Structure  and Membership
Per its charter, ACIP can consist of up to 19 voting
members  who have clinical, scientific, and public health
expertise in immunization. One lay member is a consumer
representative with knowledge about social and community
aspects of immunization programs. In addition, several
federal health officials and representatives from national
health organizations (e.g., American Academy of
Pediatrics) serve as nonvoting representatives.

Voting members  are appointed by the HHS Secretary and
serve overlapping terms of up to four years. Anyone can
apply to become a member, with selection based on
meeting certain qualifications. Per HHS policy, the
department seeks to balance committee membership in
terms of points of view, professional training, and
backgrounds.


Recommendation Process and Criteria
ACIP  recommendations regarding vaccines and their use
are related to, but distinct from, the U.S. Food and Drug
Administration's (FDA's) licensure or authorization of
vaccines. Per its charter, ACIP recommendations are
focused on the control of vaccine-preventable diseases,
whereas FDA  generally focuses its review on the safety and
efficacy of vaccines and the processes used to manufacture
them. ACIP typically makes its recommendations after
FDA  has approved or authorized a new vaccine (or an
existing vaccine for a new indication). Per a requirement
added by the 21st Century Cures Act of 2016 (Cures Act;
P.L. 114-255, §3091), ACIP must consider any newly
licensed vaccine (or new indication) at the committee's next
regularly scheduled meeting. In addition, ACIP may also
make recommendations  regarding other medical products
(e.g., antimicrobial therapy) shown to be effective against a
disease for which a vaccine is available.

In its review and recommendation process, ACIP weighs
whether the benefits of recommending a certain vaccine for
a certain population-including the impact of such a
recommendation  on disease transmission or reduction in
disease, hospitalizations, and deaths-outweigh any
possible harms at an individual or population level. Harms
could include, for example, considerations around vaccine
safety (individual level) or disease distribution within the
population (population level). ACIP also considers the
potential public health importance, quality of the evidence
used, implementation considerations, equity, and values and
preferences of the people affected. In a few cases, ACIP's
recommendations have differed from FDA-approved
indications for use, resulting in recommendations for off-
label use of vaccines.

ACIP  recommendations can be informed by the FDA-
approved vaccine label, published and unpublished clinical
data from the vaccine manufacturer, and other independent
studies. ACIP follows the Grading of Recommendations,
Assessment, Development and Evaluation (GRADE)
approach for determining the quality and strength of
evidence for recommendations. The GRADE  approach is
commonly  used for formulating health recommendations in
the United States and around the world.

ACIP  holds full-committee public meetings at least three
times per year to review evidence and vote on new
recommendations. Outside these meetings, ACIP members
serve on work groups to review evidence regarding specific
vaccines on an ongoing basis. ACIP work groups can solicit
and consider public comments. ACIP work groups present
evidence reviews and draft recommendations to the full
committee for consideration. Final recommendations must
receive a vote from a majority of the committee.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Already a HeinOnline Subscriber?

profiles profiles most